Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Here is the latest stock price and chart of Eris Lifesciences Limited. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes | Apr 20, 2018 (Close) | ||
---|---|---|---|
Price (Rs)791.15 | Open (Rs) 783.20 | High (Rs) 799.00 | Low (Rs) 783.20 |
% Change-0.41 | Volume 579 | Value (Rs) 458,616 | 52-Week H/L 896.00 / 510.50 |
Live NSE Quotes | Apr 23, 2018 9:19:59 AM | ||
---|---|---|---|
Price (Rs)796.20 | Open (Rs) 794.85 | High (Rs) 797.90 | Low (Rs) 792.25 |
% Change-0.23 | Volume 195 | Value (Rs) 154,922 | 52-Week H/L 849.00 / 510.00 |
BSE Sensex | CNX Nifty |
PERIOD |
ERIS LIFESCIENCES LIMITED share price is down 0.2% to Rs 796.2 on the NSE. The total volume of shares traded is 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.0%. And the benchmark NIFTY 50 is at 10,557.4 (down 0.1%).
Over the last 30 days, the ERIS LIFESCIENCES LIMITED share price is down 2.5%.
| |
S&P Information Technology index ended higher by 5% in Friday's trade. The rally was led by stocks such as Cyient, Mindtree, Tata Consultancy Service (TCS).
Exposure to high margin specialty products offers promising growth prospects.
US business was hit by pricing pressure although there was growth sequentially led by new product launches.
Price erosion in generic US drugs continues but seems to be bottoming out.
Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.
The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.
More Views on NewsIt is basically a supply problem with not enough currency going around in the financial system.
I'm going to tell you certain things about the inner workings of the industry so that you know why his advice is likely to be at best junk, and at worst dangerous.
The imaginary stock price of IIM Ahmedabad could have rivalled the returns from Titan and Asian Paints thanks to its enormous pricing power.
How you can increase your odds of seizing multibagger stocks and rake in the moolah by investing in small cap stocks.
PersonalFN explains how a dependable robo-advisory platform can help you create your personalized asset allocation plan
More
| |